Atlas Trials

Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

Clinical trial NCT00742495 · TERMINATED

Trial details

NCT number
NCT00742495
Sponsor
Mundipharma Research Limited
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory T-cell Acute Lymphoblastic LeukaemiaB-cell Precursor Acute Lymphoblastic LeukaemiaT-cell Non-Hodgkin's Lymphoma
Start date
2009-03-01
Primary completion
2010-09-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.